Breaking News

Gut Microbiome Therapy to be Approved in the Next Two Years

The promise of microbiome-based therapeutics is rapidly progressing towards real world applications.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Speaking from CPHI Frankfurt, Christian Roghi, director of Microbiome Solutions, predicted microbial therapy will be the next big breakthrough in novel therapies, rivalling discoveries like mABs, siRNA and CART-T cells. “We are seeing huge interest in microbiome research, especially in the last five years,” he said. “There have been a large number of publications describing both the science and the potential benefits of a healthy microbiome.” In total there are roughly 524 microbiome-based...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters